Cargando…

Adenovirus Vaccine Containing Truncated SARS-CoV-2 Spike Protein S1 Subunit Leads to a Specific Immune Response in Mice

The development of an efficient and safe coronavirus disease 2019 (COVID-19) vaccine is a crucial approach for managing the severe acute respiratory disease coronavirus 2 (SARS-CoV-2) pandemic in light of current conditions. In this study, we produced a shortened segment of the optimized SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Keda, Shi, Danrong, Li, Chaonan, Fang, Zhongbiao, Guo, Yikai, Jiang, Wenjie, Li, Jiaxuan, Li, Hongyu, Yao, Hangping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968167/ https://www.ncbi.nlm.nih.gov/pubmed/36851306 http://dx.doi.org/10.3390/vaccines11020429

Ejemplares similares

Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants
por: Li, Chaonan, et al.
Publicado: (2022)

An updated review of SARS‐CoV‐2 detection methods in the context of a novel coronavirus pandemic
por: Zhang, Yuxuan, et al.
Publicado: (2022)

Application of bioreactor technology for cell culture-based viral vaccine production: Present status and future prospects
por: Fang, Zhongbiao, et al.
Publicado: (2022)

The role of SARS-CoV-2 N protein in diagnosis and vaccination in the context of emerging variants: present status and prospects
por: Song, Wanchen, et al.
Publicado: (2023)

Recombinant human interferon-α1b inhibits SARS-CoV-2 better than interferon-α2b in vitro
por: Shi, Danrong, et al.
Publicado: (2022)

Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats
por: Liu, Ran-Yi, et al.
Publicado: (2005)

Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus
por: Zheng, Xiaoqin, et al.
Publicado: (2021)

Delta (B.1.617.2) inactivated vaccine candidate elicited neutralizing antibodies to SARS-CoV-2 and circulating variants in rhesus macaques
por: Zhang, Yanjun, et al.
Publicado: (2023)

Production of novel SARS‐CoV‐2 Spike truncations in Chinese hamster ovary cells leads to high expression and binding to antibodies
por: Minami, Shiaki A., et al.
Publicado: (2022)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
por: Yu, Sicong, et al.
Publicado: (2021)

Optimization of Vero Cells Grown on a Polymer Fiber Carrier in a Disposable Bioreactor for Inactivated Coxsackievirus A16 Vaccine Development
por: Chen, Keda, et al.
Publicado: (2021)

Influence of intron and exon splicing enhancers on mammalian cell expression of a truncated spike protein of SARS-CoV and its implication for subunit vaccine development
por: Chang, Chia-Yin, et al.
Publicado: (2006)

Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses
por: Lin, Yajie, et al.
Publicado: (2022)

Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice
por: Lu, Mingqing, et al.
Publicado: (2022)

Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo
por: Yao, Hangping, et al.
Publicado: (2020)

Role of tumor microenvironment in cancer progression and therapeutic strategy
por: Wang, Qingjing, et al.
Publicado: (2023)

Neutralizing Antibodies against the SARS-CoV-2 Delta and Omicron BA.1 following Homologous CoronaVac Booster Vaccination
por: Li, Jianhua, et al.
Publicado: (2022)

Structure/Function Analysis of Truncated Amino-Terminal ACE2 Peptide Analogs That Bind to SARS-CoV-2 Spike Glycoprotein
por: Mackin, Robert T., et al.
Publicado: (2022)

SARS-CoV-2 N protein potentiates host NPM1-snoRNA translation machinery to enhance viral replication
por: Wang, Hui, et al.
Publicado: (2022)

Molecular Architecture of the SARS-CoV-2 Virus
por: Yao, Hangping, et al.
Publicado: (2020)

Functional Analysis of a Wheat AGPase Plastidial Small Subunit with a Truncated Transit Peptide
por: Yang, Yang, et al.
Publicado: (2017)

Dose-Related Aberrant Inhibition of Intracellular Perforin Expression by S1 Subunit of Spike Glycoprotein That Contains Receptor-Binding Domain from SARS-CoV-2
por: Huang, Chun-Fu, et al.
Publicado: (2021)

In situ architecture and membrane fusion of SARS-CoV-2 Delta variant
por: Song, Yutong, et al.
Publicado: (2023)

A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein
por: Pang, Wei, et al.
Publicado: (2022)

Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1
por: Cory, Theodore J., et al.
Publicado: (2021)

Recombinant subunits of SARS‐CoV‐2 spike protein as vaccine candidates to elicit neutralizing antibodies
por: Noorabad Ghahroodi, Faezeh, et al.
Publicado: (2022)

Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2
por: Zheng, Zhiqiang, et al.
Publicado: (2020)

Virus-binding activity of the truncated C subunit of porcine aminopeptidase N expressed in Escherichia coli
por: Sun, Dongbo, et al.
Publicado: (2011)

Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
por: Alluhaybi, Khalid A., et al.
Publicado: (2021)

SARS-CoV-2 omicron BA.1.1 is highly resistant to antibody neutralization of convalescent serum from the origin strain
por: Li, Jianhua, et al.
Publicado: (2023)

561. Recombinant Adenovirus Carrying Spike Gene Induces Effective Humoral and Cellular Immunity Against SARS-CoV in Rats
Publicado: (2004)

Heterologous chimpanzee adenovirus vector immunizations for SARS-CoV-2 spike and nucleocapsid protect hamsters against COVID-19
por: Hasanpourghadi, Mohadeseh, et al.
Publicado: (2023)

An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission
por: Tabynov, Kairat, et al.
Publicado: (2022)

Next-to-leading order matrix elements and truncated showers
por: Hoche, Stefan, et al.
Publicado: (2010)

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine
por: He, Yuxian, et al.
Publicado: (2004)

Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation
por: Chen, Hsu-Yu, et al.
Publicado: (2021)

Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2
por: Ng, Kim Tien, et al.
Publicado: (2021)

Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit
por: Kandeel, Mahmoud, et al.
Publicado: (2021)

Proinflammatory Responses in SARS-CoV-2 and Soluble Spike Glycoprotein S1 Subunit Activated Human Macrophages
por: Chiok, Kim, et al.
Publicado: (2023)

SARS-CoV-2 Spike protein S2 subunit modulates γ-secretase and enhances amyloid-β production in COVID-19 neuropathy
por: Ma, Guanqin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ec4f4dl9c5ihddrf48b45ijpot